Advances in biomedical imaging, bioengineering, and related technologies for the development of biomarkers of pancreatic disease summary of a national institute of diabetes and digestive and kidney diseases and national institute of biomedical imaging and bioengineering workshop

Pancreas

Volumn 44, Issue 8, 2015, Pages 1185-1194

  Kelly, Kimberly A ^a   Hollingsworth, Michael A ^b   Brand, Randall E ^c   Liu, Christina H ^d   Singh, Vikesh K ^e   Srivastava, Sudhir ^d   Wasan, Ajay D ^c   Yadav, Dhiraj ^c   Andersen, Dana K ^f  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Biomarkers; Chronic pancreatitis; Circulating tumor cells; Exosomes; Molecular imaging; Pancreatic cancer

Indexed keywords

BIOLOGICAL MARKER; CELL MARKER;

BIOENGINEERING; CANCER DIAGNOSIS; CHRONIC PANCREATITIS; CIRCULATING TUMOR CELL; CONFERENCE PAPER; EARLY CANCER; EXOSOME; FLUORESCENCE IMAGING; GASTROINTESTINAL DISEASE; HUMAN; IMAGING; INFLAMMATION; KIDNEY DISEASE; MOLECULAR IMAGING; NATIONAL HEALTH ORGANIZATION; PAIN; PANCREAS CANCER; PANCREAS DISEASE; PANCREAS FUNCTION; PRIORITY JOURNAL; PROTEOMICS; RISK ASSESSMENT; WORKSHOP; DIAGNOSTIC IMAGING; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PROCEDURES; TRENDS; UNITED STATES;

BIOENGINEERING; BIOMARKERS; DIAGNOSTIC IMAGING; HUMANS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (U.S.); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (U.S.); PANCREATIC DISEASES; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; UNITED STATES;

EID: 84944396574     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000552     Document Type: Conference Paper

References (72)

1. Ammann RW, Buehler H, Muench R, et al. Differences in the natural history of idiopathic (nonalcoholic) and alcoholic chronic pancreatitis. A comparative long-term study of 287 patients. Pancreas. 1987;2:368-377.
2. Lankisch PG, Löhr-Happe A, Otto J, et al. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion. 1993;54:148-155.
3. Layer P, Yamamoto H, Kalthoff L, et al. The different courses of early-and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology. 1994;107:1481-1487.
4. Wilcox CM, Yadav D, Ye T, et al. Chronic pancreatitis pain pattern and severity are independent of abdominal imaging findings. Clin Gastroenterol Hepatol. 2015;13:552-60.
5. Bhutani MS, Arantes VN, Verma D, et al. Histopathologic correlation of endoscopic ultrasound findings of chronic pancreatitis in human autopsies. Pancreas. 2009;38:820-824.
6. Yusoff IF, Sahai AV. A prospective, quantitative assessment of the effect of ethanol and other variables on the endosonographic appearance of the pancreas. Clin Gastroenterol Hepatol. 2004;2:405-409.
7. van Geenen EJ, Smits MM, Schreuder TC, et al. Smoking is related to pancreatic fibrosis in humans. Am J Gastroenterol. 2011;106:1161-1166.
8. Al-Haddad M, Khashab M, Zyromski N, et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas. 2009;38:672-675.
9. Vitale GC, Davis BR, Zavaleta C, et al. Endoscopic retrograde cholangiopancreatography and histopathology correlation for chronic pancreatitis. Am Surg. 2009;75:649-653.
10. LeBlanc JK, Chen JH, Al-Haddad M, et al. Endoscopic ultrasound and histology in chronic pancreatitis: how are they associated? Pancreas. 2014; 43:440-444.
11. Varadarajulu S, Eltoum I, Tamhane A, et al. Histopathologic correlates of noncalcific chronic pancreatitis by EUS: a prospective tissue characterization study. Gastrointest Endosc. 2007;66:501-509.
12. Albashir S, Bronner MP, Parsi MA, et al. Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. Am J Gastroenterol. 2010;105:2498-2503.
13. Chong AK, Hawes RH, Hoffman BJ, et al. Diagnostic performance of EUS for chronic pancreatitis: a comparison with histopathology. Gastrointest Endosc. 2007;65:808-814.
14. Wallace MB, Hawes RH, Durkalski V, et al. The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers. Gastrointest Endosc. 2001;53:294-299.
15. Gardner TB, Gordon SR. Interobserver agreement for pancreatic endoscopic ultrasonography determined by same day back-to-back examinations. J Clin Gastroenterol. 2011;45:542-545.
16. Catalano MF, Sahai A, Levy M, et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc. 2009;69:1251-1261.
17. Stevens T, Lopez R, Adler DG, et al. Multicenter comparison of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of chronic pancreatitis. Gastrointest Endosc. 2010;71:519-526.
18. Del Pozo D, Poves E, Tabernero S, et al. Conventional versus Rosemont endoscopic ultrasound criteria for chronic pancreatitis: interobserver agreement in same day back-to-back procedures. Pancreatology. 2012;12: 284-287.
19. Janssen J, Schlörer E, Greiner L. EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. Gastrointest Endosc. 2007;65: 971-978.
20. Xu W, Shi J, Li X, et al. Endoscopic ultrasound elastography for differentiation of benign and malignant pancreatic masses: a systemic review and meta-analysis. Eur J Gastroenterol Hepatol. 2013;25:218-224.
21. Janssen J, Papavassiliou I. Effect of aging and diffuse chronic pancreatitis on pancreas elasticity evaluated using semiquantitative EUS elastography. Ultraschall Med. 2014;35:253-258.
22. Wu B, Conwell DL. The endoscopic pancreatic function test. Am J Gastroenterol. 2009;104:2381-2383.
23. Stevens T, Conwell DL, Zuccaro G Jr, et al. A prospective crossover study comparing secretin-stimulated endoscopic and Dreiling tube pancreatic function testing in patients evaluated for chronic pancreatitis. Gastrointest Endosc. 2008;67:458-466.
24. Ketwaroo G, Brown A, Young B, et al. Defining the accuracy of secretin pancreatic function testing in patients with suspected early chronic pancreatitis. Am J Gastroenterol. 2013;108:1360-1366.
25. Kadiyala V, Lee LS, Banks PA, et al. Cigarette smoking impairs pancreatic duct cell bicarbonate secretion. JOP. 2013;14:31-38.
26. LaRusch J, Jung J, General IJ, et al. Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis. PLoS Genet. 2014;10:e1004376.
27. Abu Dayyeh BK, Conwell D, Buttar NS, et al. Pancreatic juice prostaglandin e2 concentrations are elevated in chronic pancreatitis and improve detection of early disease. Clin Transl Gastroenterol. 2015;6:e72.
28. Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging. 2013;37:544-555.
29. Singh S, Venkatesh SK, Wang Z, et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol. 2015;13:440-451.
30. Shi Y, Glaser KJ, Venkatesh SK, et al. Feasibility of using 3D MR elastography to determine pancreatic stiffness in healthy volunteers. J Magn Reson Imaging. 2015;41:369-375.
31. Yadav D, O'Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol. 2012;107: 1096-1103.
32. Oiva J, Mustonen H, Kylänpää ML, et al. Patients with acute pancreatitis complicated by organ dysfunction show abnormal peripheral blood polymorphonuclear leukocyte signaling. Pancreatology. 2013;13:118-124.
33. Xue J, Sharma V, Hsieh MH, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 2015; 6:7158.
34. Zhang H, Neuhöfer P, Song L, et al. IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. J Clin Invest. 2013;123: 1019-1031.
35. Emmrich J, Weber I, Nausch M, et al. Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma. Digestion. 1998;59: 192-198.
36. Apte MV, Pirola RC, Wilson JS. Pancreatic stellate cells: a starring role in normal and diseased pancreas. Front Physiol. 2012;3:344.
37. Schmitz-Winnenthal H, Pietsch DH, Schimmack S, et al. Chronic pancreatitis is associated with disease-specific regulatory T-cell responses. Gastroenterology. 2010;138:1178-1188.
38. Swanson BJ, McDermott KM, Singh PK, et al. MUC1 isa counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion. Cancer Res. 2007;67:10222-10229.
39. Eggers JP, Grandgenett PM, Collisson EC, et al. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras. Clin Cancer Res. 2011;17:6140-6150.
40. Fink DM, Connor AL, Kelley PM, et al. Nerve growth factor regulates neurolymphatic remodeling during corneal inflammation and resolution. PLoS One. 2014;9:e112737.
41. Kelleher SL, McCormick NH, Velasquez V, et al. Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland. Adv Nutr. 2011;2:101-111.
42. Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate. 1998; 35:285-296.
43. Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007;463:211-217.
44. Sanyal R, Darroudi F, Parzefall W, et al. Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis. 1997;12:297-303.
45. Esqueda AC, López JA, Andreu-de-Riquer G, et al. A new gadolinium-based MRI zinc sensor. J Am Chem Soc. 2009;131: 11387-11391.
46. Lubag AJ, De Leon-Rodriguez LM, Burgess SC, et al. Noninvasive MRI of β-cell function using a Zn2+-responsive contrast agent. Proc Natl Acad Sci USA. 2011;108:18400-18405.
47. Paulo JA, Kadiyala V, Lee LS, et al. Proteomic analysis (GeLC-MS/MS) of ePFT-collected pancreatic fluid in chronic pancreatitis. J Proteome Res. 2012;11:1897-1912.
48. Garai E, Sensarn S, Zavaleta CL, et al. A real-time clinical endoscopic system for intraluminal, multiplexed imaging of surface-enhanced Raman scattering nanoparticles. PLoS One. 2015;10:e0123185.
49. Rogalla S, Contag CH. Early cancer detection at the epithelial surface. Cancer J. 2015;21:179-187.
50. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5-29.
51. Canto MI, Harinck F, Hruban RH, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62: 339-347.
52. Dimastromatteo J, Houghton JL, Lewis JS, et al. Challenges of Pancreatic Cancer. Cancer J. 2015;21:188-193.
53. Reynolds F, Panneer N, Tutino CM, et al. A functional proteomic method for biomarker discovery. PLoS One. 2011;6:e22471.
54. Pysz MA, Machtaler SB, Seeley ES, et al. Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection. Radiology. 2015;274:790-799.
55. Foygel K, Wang H, Machtaler S, et al. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology.2013;145:885-894.
56. Viola-Villegas NT, Carlin SD, Ackerstaff E, et al. Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer. Proc Natl Acad Sci USA. 2014;111:7254-7259.
57. Huang W, Li X, Morris EA, et al. The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo. Proc Natl Acad Sci USA. 2008;105:17943-17948.
58. Jacobs I, Strijkers GJ, Keizer HM, et al. A novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI. Magn Reson Med. 2015 [Epub ahead of print].
59. Obuz F, Bora S, Sarioglu S. Malignant islet cell tumor of the pancreas associated with portal venous thrombus. Eur Radiol. 2001;11: 1642-1644.
60. Akisik MF, Sandrasegaran K, Bu G, et al. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy. Radiology. 2010;256:441-449.
61. Bali MA, Metens T, Denolin V, et al. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters. Radiology. 2011;261:456-466.
62. Yao X, Zeng M, Wang H, et al. Evaluation of pancreatic cancerby multiple breath-hold dynamic contrast-enhanced magnetic resonance imaging at 3.0T. Eur J Radiol. 2012;81:e917-e922.
63. Kenner BJ, Chari ST, Cleeter DF, et al. Early detection of sporadic pancreatic cancer: strategic map for innovation-a white paper. Pancreas. 2015;44:686-692.
64. Pannala R, Basu A, Petersen GM, et al. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009;10:88-95.
65. Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008; 134:981-987.
66. Hart PA, Kamada P, Rabe KG, et al. Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus. Pancreas. 2011;40:768-772.
67. Gibbons C, Dackor R, Dunworth W, et al. Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol Endocrinol. 2007; 21:783-796.
68. Aggarwal G, Ramachandran V, Javeed N, et al. Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in p. cells and mice. Gastroenterology. 2012;143:1510-1517.
69. Korc M. Pancreatic cancer-associated diabetes is an "exosomopathy". Clin Cancer Res. 2015;21:1508-1510.
70. Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349-361.
71. Rhim AD, Thege FI, Santana SM, et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology. 2014;146:647-651.
72. Tauro BJ, Greening DW, Mathias RA, et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 2012;56:293-304.